Which hedge funds own IMCR? IMMUNOCORE HLDGS PLC, Q2 2026 13F holders
Healthcare · Open on the interactive board
10 of the hedge funds tracked by WhaleCreep disclosed a position in IMCR (IMMUNOCORE HLDGS PLC) in their Q2 2026 13F filings, worth $156.0m in total. The largest holder by portfolio weight is Moore Capital Management at 0.2% of its book.
10tracked managers holding
0opened this quarter
0exited this quarter
Which hedge funds hold IMCR? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Moore Capital Management | Q2 2026 | 0.2% | $8.7m | 274,663 | 39% | added |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $31.4m | 990,280 | -10% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $50.7m | 1,597,037 | 29% | added |
| Woodline Partners | Q2 2026 | 0.0% | $10.1m | 316,762 | 0% | held |
| Marshall Wace | Q2 2026 | 0.0% | $18.8m | 590,941 | 228% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $1.1m | 34,450 | 110% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $18.0m | 566,761 | 146% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $12.9m | 405,116 | 21% | added |
| Bridgewater Associates | Q2 2026 | 0.0% | $1.2m | 36,707 | 94% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $3.3m | 102,400 | -38% | reduced |
How has hedge fund ownership of IMCR changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $156.0m |
| Q1 2026 | 10 | $114.5m |
| Q4 2025 | 5 | $34.5m |
| Q3 2025 | 4 | $33.0m |
| Q2 2025 | 4 | $41.1m |
| Q1 2025 | 4 | $32.7m |
| Q4 2024 | 3 | $24.4m |
| Q3 2024 | 3 | $23.4m |
| Q2 2024 | 4 | $38.5m |
| Q1 2024 | 4 | $74.1m |
| Q4 2023 | 3 | $50.9m |
| Q3 2023 | 4 | $82.2m |
| Q2 2023 | 4 | $139.7m |
| Q1 2023 | 4 | $126.3m |
| Q4 2022 | 4 | $152.5m |
| Q3 2022 | 4 | $162.9m |
Counts every tracked manager that disclosed IMCR in that quarter's filing, including managers that have since stopped filing.